What is the address of BOURMANNE MEDICA S.P.R.L. Civile?

The registered office of BOURMANNE MEDICA S.P.R.L. Civile is located at Avenue Bel Air 31, 1330 Rixensart.

Is BOURMANNE MEDICA S.P.R.L. Civile still active?

Yes. According to the CBE (30 September 2026) BOURMANNE MEDICA S.P.R.L. Civile is active, legal situation “Normale toestand”, started on 17 December 2008.

Is BOURMANNE MEDICA S.P.R.L. Civile registered on Peppol?

No, BOURMANNE MEDICA S.P.R.L. Civile is currently not registered on the Peppol network.

What is the enterprise number of BOURMANNE MEDICA S.P.R.L. Civile?

The enterprise number of BOURMANNE MEDICA S.P.R.L. Civile is BE0808572994.

When was BOURMANNE MEDICA S.P.R.L. Civile founded?

BOURMANNE MEDICA S.P.R.L. Civile was founded on 17 December 2008.

Who are the directors of BOURMANNE MEDICA S.P.R.L. Civile?

According to the 2024 annual accounts, the directors of BOURMANNE MEDICA S.P.R.L. Civile are: Eric BOURMANNE.

Is BOURMANNE MEDICA S.P.R.L. Civile a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 December 2008; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did BOURMANNE MEDICA S.P.R.L. Civile make in 2024?

BOURMANNE MEDICA S.P.R.L. Civile posted a profit after taxes of € 154,522 in financial year 2024.

What is the revenue of BOURMANNE MEDICA S.P.R.L. Civile?

As a small company, BOURMANNE MEDICA S.P.R.L. Civile is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 231,294.

BOURMANNE MEDICA S.P.R.L. Civile (Private Limited)

Dossier BOURMANNE MEDICA S.P.R.L. Civile, printed on 30 September 2026 from databakkes.be/en/0808572994/bourmanne-medica-s-p-r-l-civile. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

BOURMANNE MEDICA S.P.R.L. Civile from Rixensart, company number BE0808572994, closed financial year 2024 with a result of € 154,522 after tax. For that financial year BOURMANNE MEDICA S.P.R.L. Civile recorded a gross margin of € 231,294 and equity of € 177,353. Compared with financial year 2023, the result moved from € 119,427 to € 154,522. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 13, 2025.

What it is worth Growing

€ 177,353

▲ 14% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 154,522

▲ 29% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 96,958

▲ 74% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 132,500 paid out

86 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2024

Vehicles and equipment

€ 2,643

▼ 46% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 176,097

▼ 52% vs 2023

€ 28,417 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Taxes

€ 83,250

▲ 18% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 189,899 Gross margin 2021: € 189,899 First fiscal year in the series	€ 184,269 Gross margin 2022: € 184,269 ▼ 3% vs 2021 (€ 189,899) Unfavourable step	€ 187,690 Gross margin 2023: € 187,690 ▲ 2% vs 2022 (€ 184,269) Favourable step	€ 231,294 Gross margin 2024: € 231,294 ▲ 23% vs 2023 (€ 187,690) Favourable step	▲ 23%
Profit after taxes	€ 109,901 Profit after taxes 2021: € 109,901 First fiscal year in the series	€ 111,175 Profit after taxes 2022: € 111,175 ▲ 1% vs 2021 (€ 109,901) Favourable step	€ 119,427 Profit after taxes 2023: € 119,427 ▲ 7% vs 2022 (€ 111,175) Favourable step	€ 154,522 Profit after taxes 2024: € 154,522 ▲ 29% vs 2023 (€ 119,427) Favourable step	▲ 29%
Equity	€ 149,729 Equity 2021: € 149,729 First fiscal year in the series	€ 155,904 Equity 2022: € 155,904 ▲ 4% vs 2021 (€ 149,729) Favourable step	€ 155,331 Equity 2023: € 155,331 Unchanged (€ 155,904) Unfavourable step	€ 177,353 Equity 2024: € 177,353 ▲ 14% vs 2023 (€ 155,331) Favourable step	▲ 14%
Total debts	€ 422,468 Total debts 2021: € 422,468 First fiscal year in the series	€ 421,095 Total debts 2022: € 421,095 Unchanged (€ 422,468) Favourable step	€ 439,941 Total debts 2023: € 439,941 ▲ 4% vs 2022 (€ 421,095) Unfavourable step	€ 259,475 Total debts 2024: € 259,475 ▼ 41% vs 2023 (€ 439,941) Favourable step	▼ 41%
Cash	€ 22,497 Cash 2021: € 22,497 First fiscal year in the series	€ 42,680 Cash 2022: € 42,680 ▲ 90% vs 2021 (€ 22,497) Favourable step	€ 55,580 Cash 2023: € 55,580 ▲ 30% vs 2022 (€ 42,680) Favourable step	€ 96,958 Cash 2024: € 96,958 ▲ 74% vs 2023 (€ 55,580) Favourable step	▲ 74%
Land & buildings	€ 525,438 Land & buildings 2021: € 525,438 First fiscal year in the series	€ 511,139 Land & buildings 2022: € 511,139 ▼ 3% vs 2021 (€ 525,438) Unchanged	€ 496,841 Land & buildings 2023: € 496,841 ▼ 3% vs 2022 (€ 511,139) Unchanged	€ 286,323 Land & buildings 2024: € 286,323 ▼ 42% vs 2023 (€ 496,841) Unchanged	▼ 42%
Retained profit	€ 137,329 Retained profit 2021: € 137,329 First fiscal year in the series	€ 143,504 Retained profit 2022: € 143,504 ▲ 4% vs 2021 (€ 137,329) Favourable step	€ 142,931 Retained profit 2023: € 142,931 Unchanged (€ 143,504) Unfavourable step	€ 164,953 Retained profit 2024: € 164,953 ▲ 15% vs 2023 (€ 142,931) Favourable step	▲ 15%
Dividend	€ 75,000 Dividend 2021: € 75,000 First fiscal year in the series	€ 105,000 Dividend 2022: € 105,000 ▲ 40% vs 2021 (€ 75,000) Unchanged	€ 120,000 Dividend 2023: € 120,000 ▲ 14% vs 2022 (€ 105,000) Unchanged	€ 132,500 Dividend 2024: € 132,500 ▲ 10% vs 2023 (€ 120,000) Unchanged	▲ 10%
Bank debt	€ 386,382 Bank debt 2021: € 386,382 First fiscal year in the series	€ 340,700 Bank debt 2022: € 340,700 ▼ 12% vs 2021 (€ 386,382) Favourable step	€ 369,441 Bank debt 2023: € 369,441 ▲ 8% vs 2022 (€ 340,700) Unfavourable step	€ 176,097 Bank debt 2024: € 176,097 ▼ 52% vs 2023 (€ 369,441) Favourable step	▼ 52%
Balance sheet total	€ 572,197 Balance sheet total 2021: € 572,197 First fiscal year in the series	€ 576,999 Balance sheet total 2022: € 576,999 ▲ 1% vs 2021 (€ 572,197) Unchanged	€ 595,272 Balance sheet total 2023: € 595,272 ▲ 3% vs 2022 (€ 576,999) Unchanged	€ 436,828 Balance sheet total 2024: € 436,828 ▼ 27% vs 2023 (€ 595,272) Unchanged	▼ 27%

Key figures of BOURMANNE MEDICA S.P.R.L. Civile, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to BOURMANNE MEDICA S.P.R.L. Civile?

What happened at BOURMANNE MEDICA S.P.R.L. Civile in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 13, 2025 New annual accounts for financial year 2024: profit of € 154,522 (▲ 29% vs 2023). filed late Source: NBB ↗
Dec 17, 2008 New establishment in Ath. KBO
Dec 17, 2008 Start of the company according to the CBE. KBO

In short

From € 109,901 profit in 2021 to € 154,522 profit in 2024.

Paid € 183,127 in corporate taxes since 2021.

Best year ever: 2024, with € 154,522 profit.

Paid out € 432,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at BOURMANNE MEDICA S.P.R.L. Civile? We notify you, reason included.

Follow BOURMANNE MEDICA S.P.R.L. Civile

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Eric BOURMANNE

BOURMANNE MEDICA S.P.R.L. Civile

Behind BOURMANNE MEDICA S.P.R.L. Civile is Eric BOURMANNE.

See the full network in the app

Directors

According to the 2024 annual accounts

Eric BOURMANNE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Bel Air 31

1330 Rixensart

2.298.978.885

Rue Maria Thomée 1

7800 Ath

Active since 17 December 2008

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0808.572.994
VAT number: BE 0808.572.994
Registered office: Avenue Bel Air 31, 1330 Rixensart
Names & denominations: BOURMANNE MEDICA S.P.R.L. Civile
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 December 2008
Peppol: Not registered
Contact: [email protected] +32477427320

View on CBE Public ↗ Annual accounts (NBB) ↗